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A B S T R A C T
Purpose: The aim of this study was to compare the frequency of anxiety symptoms between patients
with frontal lobe epilepsy (FLE) and generalized epilepsy (GE).
Methods: Forty and 78 patients with FLE and GE respectively were enrolled in the study. Anxiety
symptoms were measured with the Hamilton anxiety rating scale (HARS) and the anxiety subscale of the
hospital anxiety and depression scale (HADSA).
Results: Compared to the GE group, the FLE group had signiﬁcantly higher HARS (10.9  8.7 vs. 7.9  6.8,
p = 0.039) scores. Signiﬁcant correlations were also found between anxiety symptoms and epilepsy-related
variables, particularly with the seizure frequency and the number of currently taken anti-epileptic drugs.
Conclusion: Anxiety symptoms are more common in patients with FLE in comparison to those with GE.
Further studies are warranted to clarify the relationship between anxiety symptoms and FLE.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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Anxiety disorders are common in patients with epilepsy1 and
adversely affect patients’ quality of life.2 Possible risk factors for
anxiety in epilepsy may include seizure frequency, perceived
stigma, and late onset, treatment refractory and focal epilepsies.3
Anxiety disorders occur in approximately 20% of patients with
focal epilepsies.4 A recent study on the prevalence of anxiety
disorders in patients with temporal lobe epilepsy (TLE), the most
common type of focal epilepsy, reported a rate of 18%.5 Frontal lobe
epilepsy (FLE), another common type of focal epilepsy, takes up
about 15% of all patients with pharmaco-resistant epilepsies. FLE is
associated with psychopathology including executive dysfunc-
tions, cognitive impairment, hyperactivity, obsession, and addic-
tive behavior.6 It is yet unknown if FLE is associated with anxiety
symptoms. A comparison of 67 TLE patients with 64 non-TLE
patients (mostly FLE) yielded no difference in the anxiety state or
trait scores or the frequency of anxiety disorders.7 Similarly, the
personality proﬁle of 58 FLE and 39 TLE patients did not reveal
differences in anxiety-related traits.8
The aim of this study was to examine if anxiety symptoms were
more common in patients with FLE in comparison to those with
generalized epilepsy (GE). We hypothesized that the level of
anxiety symptoms would be higher in patients with FLE.* Corresponding author. Tel.: +852 2636 7760; fax: +852 2648 3394.
E-mail address: tangwk@cuhk.edu.hk (W.K. Tang).
1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.04.0122. Methods
Patients were enrolled in the study between March and June
2007. The details of the methodology have been published
elsewhere.9 Brieﬂy, consecutively assessed patients when attend-
ing the neurology outpatient clinics at Prince of Wales Hospital
were recruited. Inclusion criteria were age =/>18 years, diagnosed
with epilepsy and being literate in Chinese language. Each patient
was interviewed by a trained epileptologist who also reviewed the
medical charts to collect demographic data (age, sex, and marital
status), history of previous psychiatric illness and current medical
information. Past psychiatric history was recorded. The following
medical information was collected: age of onset, duration and
etiology of epilepsy, seizure type, time of last seizure and current
AED treatment. Epileptic syndromes were classiﬁed according to
the guidelines of the International League Against Epilepsy10,11
based on seizure semiology, EEG and imaging ﬁndings. Patients
with primary generalized seizures (based on electro-clinical
features) were classiﬁed as having generalized epilepsy. General-
ized epilepsies could have idiopathic, cryptogenic or symptomatic
etiologies.12
Anxiety symptoms were measured with the Chinese versions of
the instruments that have previously been validated and applied in
Hong Kong, namely the anxiety subscale of the hospital anxiety
and depression scale (HADSA)13,14 and the Hamilton anxiety rating
scale (HARS).15 The HADSA has 7 items with a total score ranging
from 0 to 21; HARS is a 14 items scale with a total score range of 0–
56; higher scores indicate more severe symptoms. Depressivevier Ltd. All rights reserved.
Table 1
Descriptive statistics of the generalized and frontal lobe epilepsy groups.
Generalized epilepsy (N = 78) N (%), mean  sd Frontal lobe epilepsy (N = 40) N (%), mean  sd p
Age (years) 37.2  13.2 36.3  12.7 0.769a
Sex (men) 37 (47.4) 22 (55) 0.437b
Education 0.275b
Below primary 1 (1.3) 0
Primary 8 (10.4) 4 (10)
Secondary 50 (64.9) 32 (80)
University or above 18 (23.4) 4 (10)
Marital status 0.438b
Married 44 (57.1) 18 (45)
Single 32 (41.6) 21 (52.5)
Divorced 1 (1.3) 1 (2.5)
Etiology <0.001b
Post stroke 2 (2.6) 1 (2.5)
Post infection 5 (6.4) 4 (10.0)
Post trauma 2 (2.6) 3 (7.5)
Brain tumor 0 (0.0) 2 (5.0)
Genetic/developmental 1 (1.3) 1 (2.5)
Other cause 0 (0.0) 10 (25.0)
Idiopathic 40 (51.3) 0 (0.0)
Cryptogenic 24 (30.8) 18 (45.0)
Unclassiﬁable 4 (5.1) 1 (2.5)
Duration of epilepsy (years) 14.6  9.5 16.9  14.0 0.296a
Onset age of epilepsy 22.0  15.2 19.1  14.8 0.333a
Monthly seizure frequency in past 6 months 0.6  3.2 7.4  24.2 <0.001c
Family history of epilepsy 5 (6.6) 3 (7.5) 0.419b
Past psychiatric illness 3 (3.8) 2 (5.1) 0.747b
Number of current AED treatment 1.1  0.5 2.0  1.0 <0.001c
HARS 7.9  6.8 10.9  8.7 0.039a
HADSA 5.2  3.6 6.5  4.4 0.106a
HADSD 5.1  3.5 6.6  4.2 0.050a
HADS total 10.3  6.4 13.0  7.3 0.042a
AED = antiepileptic drug; HARS = Hamilton anxiety rating scale; HADSA = hospital anxiety and depression scale subscale of anxiety; HADSD = hospital anxiety and depression
scale subscale of depression; MTS = Mesial temporal sclerosis.
a t-Test.
b Chi square test.
c Mann–Whitney U-test.
W.K. Tang et al. / Seizure 21 (2012) 457–460458symptoms were measured with the depression subscale of the
HADS (HADSD). The cut off score for possible psychopathology
were 816 and 1415 for the HADSA/HADSD and HARS, respectively.
The scales were self administered by the patients. The HADSA and
HADSD were originally developed as a self-rating instrument.14
The anxiety scores and the demographic and clinical char-
acteristics between the FLE and GE groups were compared using
the t-test and Mann–Whitney U-test. Categorical data (sex, marital
status, etiology, current AED treatment) were compared using chi
square test. Pearson’s correlation and stepwise linear multiple
regression analysis were used to explore the association of the
anxiety and depression scores with the epilepsy-related variables
(age at onset, duration of epilepsy, seizure frequency, and number
of current AEDs). All statistical tests were performed using SPSS for
Windows (Release 16.0; SPSS Inc., Chicago, IL, USA). The
signiﬁcance level of p value was set at 0.05.
The study protocol was approved by the Clinical Research Ethics
Committee of the Chinese University of Hong Kong. All participants
signed a consent form.
3. Results
A total of 247 patients completed the questionnaires, of whom
40 and 78 were classiﬁed as having FLE and GE, respectively and
were included in the analysis. Of the patients with FLE, 34 had an
MRI, which demonstrated abnormality in left, right and bilateral
frontal lobe in 6, 14, and 2 cases, respectively. No differences in age,
sex, marital status, age of onset and duration of epilepsy were
found between the two groups. GE patients were more likely to
have idiopathic etiology, less frequent seizure attacks, and lower
number of current AEDs [Table 1].In the GE group, 14 (17.9%), 22 (28.2%) and 22 (28.2%) patients
scored above the cut-off points of the HDRS, HADSA and HADSD,
respectively; the corresponding ﬁgures in the FLE group were 10
(25.0%), 16 (40.7%) and 14 (35.0%).
Compared to the GE group, the FLE group had a signiﬁcantly
higher HARS (10.9  8.7 vs. 7.9  6.8, p = 0.039) and HADS total
scores (13.0  7.3 vs. 10.3  6.4, p = 0.042). There was also a trend
that the FLE group had a higher mean HADSD scores (6.6  4.2 vs.
5.1  3.5, p = 0.050).
The HARS, HADSA, HADSD and HADS total scores were all
highly correlated with each other; the correlations ranged from
0.468 to 0.885 (p < 0.001). Signiﬁcant correlations were also found
between the anxiety and depression measures and the epilepsy-
related variables, particularly with the seizure frequency and the
number of current AEDs [Table 2].
4. Discussion
To the best of our knowledge, it was the ﬁrst study that
compared anxiety symptoms in patients with FLE and GE. FLE was
associated with more anxiety symptoms.
The mean HADSA scores of our patients ranged from 5.2 to 6.5,
which were considerably higher than the ﬁgure of 3.4 reported in a
cohort of ﬁve thousand Chinese adults in Hong Kong.17 Similarly,
the mean depressive HADSD score of the subjects (5.1–6.6) were
also higher than the ﬁgure of 3.7 reported in the Hong Kong
population.17
In this study, 22–41% of patients had signiﬁcant anxiety
symptoms measured by the HADSA. These ﬁgures are somewhat
higher than the 20.5% reported in a sample of 515 patients with
epilepsy.18 Another study using the HAMA, reported a ﬁgure of 39%
Table 2
Pearson’s correlations and linear regression (stepwise) with signiﬁcant regression coefﬁcients (betas) and multiple correlations (R2) with HARS and HADS scores as dependent
variables and epilepsy-related variables as independent variables.
Pearson’s correlations
Age of onset of epilepsy Duration of epilepsy Seizure frequency Number of AEDs
HARS 0.197 0.184
HADSA 0.191 0.198
HADSD 0.209 0.217
HADS total 0.227 0.236
Linear regression
Age of onset of epilepsy Duration of epilepsy Seizure frequency Number of AEDs R2
HARS 0.252 0.009 0.078
HADSA 0.032 0.031
HADSD 0.018 0.039
HADS total 0.010 0.047
HARS = Hamilton anxiety rating scale; HADSA = hospital anxiety and depression scale subscale of anxiety; HADSD = hospital anxiety and depression scale subscale of
depression.
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results. Our ﬁndings are in line with the majority of the literature;
the frequency of anxiety disorders was reported between 15% and
25%.3 Our results also showed that the seizure frequency and
number of AEDs were associated with anxiety and depressive
symptoms, a ﬁnding consistent with the rest of the literature.3,7
The prevalence of past psychiatric illness was very low in our
sample, much lower than the ﬁgures reported in the literature.20,21
The most likely explanation for this discrepancy is the under-
recognition of psychiatric disorders by the treating physicians.22,23
Epileptic activity in certain areas of the brain directly causes
paroxysmal anxiety, usually in the form of panic attacks. This led to
a theory of a common pathophysiological mechanism for anxiety
attacks and epilepsy, located mainly in the amygdala.24 It is worth
noting that ictal anxiety is also associated with seizures arising in
the frontal lobe, namely the anterior cingulate or orbito-frontal
cortex.25 It has been hypothesized that the anterior cingulate
regulate the activity in the amygdala and this regulatory function is
abnormal in patients with anxiety.26 A recent functional MRI
(fMRI) study found a reduced anterior cingulate activation in
patients with generalized anxiety disorder.27 Another fMRI study
reported that higher level of pretreatment anterior cingulate
cortex activity was associated with greater reductions in anxiety
following treatment with the antidepressant venlafaxine.28
Similarly, neurocircuitry models of anxiety disorders have
primarily focused on amygdalo–orbitofrontal circuit. The amyg-
dala is implicated in generating fear responses, whereas the
orbitofrontal region is linked to fear extinction.29 Reduced
orbitofrontal cortex thickness has been reported in patients with
anxiety traits30 and decreased functional connectivity between the
orbitofrontal lobe and amygdala was found in patients with social
anxiety disorder.31
In terms of neurochemistry, pathological gamma-aminobutyric
acid (GABA) serotonin function is also shared by epilepsy and
anxiety disorders. The GABAergic antiepileptic drugs, pregabalin,
barbiturates and benzodiazepines have both antiepileptic and
anxiolytic properties. In a magnetic resonance spectroscopy study,
prefrontal GABA is reduced by approximately 18% in experimen-
tally induced, acute psychological stress relative to the safe
condition.32 There is also a negative correlation between frontal
GABA level and neuroticism in healthy volunteers.33 Altered
serotonin receptor binding has been observed in patients with
epilepsy34–36 and panic disorder.37 A PET study revealed a negative
correlation between serotonin 1A binding and anxiety in the
dorsolateral prefrontal and anterior cingulate cortex in healthy
subjects.38 In conclusion, several lines of evidence suggest that
certain types of epilepsy and the spectrum of anxiety disordersshare common pathophysiology and clinical features. The poten-
tial overlap of neurobiological and clinical aspects of these two
disorders could be an important beacon for future research.
The present study has the following main limitations. The
sample size was relatively small. In addition, the DSM-IV diagnoses
for speciﬁc anxiety disorders were not assessed by a standardized
clinical interview; however, the scales used to measure anxiety are
validated and commonly employed in epileptology.39 Finally, due
to its cross-sectional design, the study could not establish any
causal relationship between psychopathology and FLE and GE.
In summary, anxiety symptoms are more common in patients
with FLE in comparison to those with GE. Further studies are
warranted to clarify the relationship between anxiety and FLE,
with the potential of devising more effective treatments for this co-
morbidity.
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